Mythological Mushrooms

02/14/2026

Thetawave Synchronization

02/10/2026

Mythological Mushrooms 🍄
Psychedelic Assisted Therapy:



*D &
:

:
PAT combines psychoactive substances with structured to treat Mental Health conditions. In this report we examine five substances. L*D, psilocybin ( ), DMT (and its traditional preparation ayahuasca), and ketamine covering current clinical research, mechanisms of action, treated conditions, comparative efficacy, safety, legal status, and integration practices. We draw on recent systematic reviews and trials, emphasizing up-to-date evidence (2022–2025).

Mechanisms of Action:
Each substance produces its effects via distinct neuropharmacology. L*D is a classic serotonergic psychedelic, acting as a strong agonist at multiple 5-HT (especially 5-HT₂A) receptors and also at dopamine D1, D2, and D4 receptors. Psilocybin is a prodrug converted in vivo to psilocin, which primarily stimulates 5-HT₂A receptors (often via a 5-HT₂A–mGluR₂ receptor complex). DMT likewise is a potent 5-HT₂A agonist, but is unique in binding other targets – for example, DMT also activates trace amine-associated receptors (TAARs) and sigma-1 receptors, contributing to neuroplastic and neuroprotective effects. Ayahuasca is a botanical brew containing DMT and MAO-inhibiting β-carbolines (harmine, harmaline) from the Banisteriopsis caapi vine. The MAOIs render DMT orally active by blocking its metabolic breakdown, extending the DMT experience to ~4–6 hours (versus ~20–30 minutes for smoked or IV DMT). Finally, ketamine is an atypical psychedelic: a non-competitive NMDA glutamate receptor antagonist. By blocking NMDA receptors, ketamine triggers a glutamate surge that rapidly stimulates synaptogenesis and increases brain-derived neurotrophic factor (BDNF), accounting for its fast-acting antidepressant effects. (Notably, NMDA antagonism is also thought to contribute to the effects of classic psychedelics like DMT.)

Current Clinical Research and Therapeutic Applications:
-Psilocybin has emerged as the most extensively studied classical psychedelic. Recent RCTs show robust antidepressant effects. For example, one JAMA trial of two guided psilocybin sessions in major depressive disorder found a mean reduction in depression scores significantly greater than placebo (niacin) at 6 weeks. In that study, 41.7% of psilocybin patients had sustained symptom response versus 11.4% for control (25.0% vs 9.1% remission). Longer-term follow-up from Johns Hopkins suggests these effects can persist: 75% of subjects remained responders and 58% in remission at 12 months post-treatment. Psilocybin-assisted therapy is also being tested for end-of-life anxiety (cancer, HIV), smoking cessation and other addictions, OCD, and alcohol use disorder. The FDA has granted psilocybin “breakthrough” status for treatment-resistant depression and for cancer-related anxiety, and phase 3 trials are underway.

-L*D research is less active today but shows promise in select areas. A systematic review of historical RCTs (1950s–70s) found that L*D-assisted therapy yielded positive outcomes especially in alcohol use disorder. Other small trials (mostly older) explored L*D for anxiety, depression, and psychosomatic conditions. Recently, “compassionate use” programs in Switzerland have allowed L*D-assisted psychotherapy under strict controls. Current trials are examining L*D (and an L*D analog semisynthetic L*D, “ML-120”) for cluster headache and other conditions. In general, L*D’s long duration (8–12 hours) makes it more challenging in clinical settings, so research has been more limited than for psilocybin.

-DMT/Ayahuasca: Pure DMT therapy is in early stages. A Phase 1 trial (SPL026) showed IV DMT to be well-tolerated (no serious adverse events) at escalating doses in healthy volunteers, and a Phase 2 study of DMT fumarate in depression is planned. IV DMT’s ultra-short duration (sub-30 minutes) could allow multiple sessions in a day. Ayahuasca (oral DMT+MAOI) has been studied in both naturalistic and small clinical trials. Observational research suggests frequent ceremonial use may lower long-term depression/anxiety scores and reduce substance use. In a controlled trial of treatment-resistant depression, a single dose of ayahuasca (with supportive setting) produced significant symptom reductions within 1–2 weeks. Ayahuasca has also been applied for alcohol and drug dependence, anxiety, and eating disorders in ritual contexts. However, RCT evidence is limited.

-Ketamine: This dissociative anesthetic is the most widely used “psychedelic” in psychiatry today, thanks to its rapid effects in depression. Its intranasal form (esketamine, brand Spravato) was FDA-approved in 2019 for treatment-resistant depression (TRD) when combined with an oral antidepressant. Dozens of trials show ketamine infusions produce fast (within hours) relief of depressive symptoms, even suicidality. Beyond depression, meta-analyses report ketamine can significantly reduce PTSD and OCD symptom scores and can reduce alcohol craving and increase abstinence in alcohol use disorder. Ketamine-assisted therapy (combining infusions with psychotherapy) is being tested for PTSD and substance use. In one large alcohol use disorder protocol, a structured ketamine-assisted regimen achieved 86% abstinence at 6 months. (However, ketamine effects tend to wane after days or weeks without repeated dosing, and long-term protocols are still being refined.)

Conditions Treated
Therapeutic applications overlap but vary by drug. Depression is a key target: ketamine has demonstrated efficacy in TRD, psilocybin has rapid antidepressant effects in major depression and mood disorders, and early data suggest ayahuasca/DMT may also reduce depressive symptoms. PTSD: Ketamine trials show symptom improvement, and M**A (not covered here) is close to approval. Research on psilocybin or L*D for PTSD is scant. Anxiety: Psilocybin is effective for cancer-related existential anxiety and general anxiety. Small studies suggest L*D and ayahuasca may reduce anxiety in serious illness or bereavement. Addiction: Psilocybin has shown promise in smoking cessation and alcohol/drug relapse prevention. L*D therapy has a long history in alcoholism treatment, with systematic reviews confirming beneficial effects. Ketamine-assisted therapy also appears to curb cravings in alcohol use disorder. Obsessive-compulsive disorder (OCD): Preliminary trials of psilocybin and ketamine reported reduced OCD symptoms (small samples). Other conditions: L*D and psilocybin have been tried for OCD, cluster headaches, and migraines. Ayahuasca has been explored for eating disorders. Overall, most evidence (and regulatory momentum) is for depression, anxiety, and substance-use disorders; other indications remain investigational.

Efficacy Comparisons:
Direct head-to-head trials of different psychedelics are lacking. However, meta-analyses give a rough sense of relative effect sizes. A recent systematic review found that psilocybin produced the largest effect on reducing mood disorder symptoms (Hedges’ g≈–1.49), comparable to ayahuasca’s (DMT’s) g≈–1.34, while L*D’s effect was smaller (g≈–0.65). (These are pooled pre-post depression/anxiety outcomes from small trials.) Another meta-analysis of ketamine found robust immediate improvements in TRD and PTSD, but with variable durability. Notably, ketamine’s effects are usually rapid but somewhat shorter-lived, whereas classic psychedelics often yield lasting benefit from one or two sessions. In clinical contexts, psilocybin and ayahuasca sessions typically require intensive therapy support but can produce enduring remission, whereas ketamine often needs repeated dosing or maintenance sessions. L*D’s efficacy data are less robust by comparison. Overall, psilocybin and ayahuasca appear at least as effective as other treatments for depression and addiction, and stronger (by effect size) than L*D, but cross-study comparisons should be made cautiously.

Practices & Models:
All modern psychedelic therapies emphasize set and setting and ongoing psychotherapy. The typical model (adopted by MAPS, Johns Hopkins, etc.) involves three phases: (1) Preparation, where therapists build rapport and educate the patient; (2) the Dosing Session, where the substance is administered in a comfortable, supervised environment with therapeutic support; and (3) Integration, a series of follow-up sessions to help the patient process the experience and apply insights to life. This model is applied to all substances in clinical research. Licensed clinicians monitor vital signs during sessions and guide the psychological experience as needed. Integration therapy may include talking, journaling, mindfulness, and even bodywork or art, to ensure insights endure.

Veteran Networking, Advertising and Marketing!

02/09/2026

Each substance produces its effects via distinct . *D is a classic serotonergic psychedelic, acting as a strong agonist at multiple 5-HT (especially 5-HT₂A) receptors and also at dopamine D1, D2, and D4 receptors. - is a prodrug converted in vivo to psilocin, which primarily stimulates 5-HT₂A receptors (often via a 5-HT₂A–mGluR₂ receptor complex)�. DMT likewise is a potent 5-HT₂A agonist, but is unique in binding other targets – for example, DMT also activates trace amine-associated receptors (TAARs) and sigma-1 receptors, contributing to neuroplastic and neuroprotective effects��. Ayahuasca is a botanical brew containing DMT and MAO-inhibiting β-carbolines (harmine, harmaline) from the Banisteriopsis caapi vine�. The MAOIs render DMT orally active by blocking its metabolic breakdown, extending the DMT experience to ~4–6 hours (versus ~20–30 minutes for smoked or IV DMT)��. Finally, ketamine is an atypical psychedelic: a non-competitive NMDA glutamate receptor antagonist�. By blocking NMDA receptors, ketamine triggers a glutamate surge that rapidly stimulates synaptogenesis and increases brain-derived neurotrophic factor (BDNF), accounting for its fast-acting antidepressant effects. Notably, NMDA antagonism is also thought to contribute to the effects of classic like .

02/08/2026

Mental Health Reprogramming:

Typical Online Therapy/Subscription Platforms charge roughly $60–$110 per week (or $70–$100/week on big platforms). While independent clinicians’ session rates commonly average around $120–$150+ per hour across many U.S. states. Use these ranges to price your paid services.

Top 3 revenue Channels to Prioritize.
1. Signature Paid Group Program:
- : 6–8 week cohort called Mental Reprogramming Bootcamp (combines , daily micro-practices, guided abundance reprogramming audio, weekly live group coaching + !
- Needed: Landing Page, 5× short videos, 3 Reprogramming Audios, Email Sequence, Onboarding DOC, Community Space!

2. Subscription Membership:
- : Monthly Membership $29–$49/mo for ongoing micro-training, weekly live drop-ins, monthly deep-dive masterclass, new downloadable reprogramming tracks.
- : vault of short modules, weekly calendar, recurring billing, retention playbook (drip content + community challenges).
- lever: retention and LTV — get to 500 members at $29/mo → $14.5k/mo recurring.

3. One-to-One Coaching / Clinical Adjunct Services
-Offer: 8-Week Intensive 1:1 Reprogramming Package (includes intake, bespoke audio program, weekly sessions) priced $1,200–$4,000 depending on clinician credentialing and inclusion of adjuncts (e.g., neurofeedback, licensed therapist).
- : high-value case study + targeted ads to lookalike audiences + organic leads from membership upsell.
- : If offering Psychotherapy or Clinical Claims. Ensure licensed clinicians deliver services and business practices follow HIPAA/state rules.
- monetization ideas (niche & scale combos) 4. Digital Mini-Products (low friction)
-10–20 minute reprogramming audio packs, worksheets, micro-courses priced $9–$49.
-Use Payhip/Gumroad or Shopify + email funnel. Good for ad creative + tripwire.

5. Licensing Content to Employers / EAPs / Clinicians
-Package modules for workplace mental health programs; price per seat or enterprise license $5–$30/employee. Market to HR and EAP vendors with ROI case studies (productivity, reduced absenteeism). High margin B2B deals.

6. Paid Assessments + Automated Report:
-10-minute Reprogramming Readiness Assessment ($7–$19) that generates a personalized audio plan and a paid upsell to coaching/cohort. Great CAC dilution.

7. Affiliate and Product Partnerships
-Curate and Recommend validated RDAs: Meditation devices, sleep aids, supplements (only legal OTC, compliant products). Earn 5–30% affiliate. Protect by transparent disclosures.

8. Hybrid Retreats & Intensives (premium)
-3–5 day virtual or in-person reprogramming intensive. Price $997–$4,500 depending on location and included services. Use as top-of-funnel prestige builder.

9. White-Label Programs for Clinicians
-Sell your curriculum + audios to clinicians/clinics to deliver under their brand; charge setup + licensing fee or revenue share.

10. App or Micro-SaaS (longer runway)
-Build an app with daily reprogramming micro-sessions and tracking. Monetize by subscription + in-app purchases. Consider MVP with web membership first to validate demand.

11. Certifications & Trainings for Practitioners
-Train other coaches/therapists in your method; charge $997–$3,997 for a certification cohort plus ongoing annual recertification fees. High margin once curriculum built.

12. Books, Workbooks, and Corporate Keynotes
-Publish a short book or workbook and sell at events + use speaking to land corporate contracts.
-Free value first: lead magnet → tripwire → core offer → ascension offer (1:1 or retreat).

-Tiered pricing increases conversions: low entry point ($7–$49) then $297–$997 flagship then $1k+ VIP.

-Use clear transformation language (what they can do after 6 weeks), concrete outcomes, and social proof/case studies. Avoid medical claims (e.g., “cure” or guaranteed clinical outcomes).

Compliance & Ethical Guardrails
***Don’t promise clinical cures or guaranteed results. Frame as “skills, tools, and practices” for symptom reduction and resilience.
***If you or partners provide therapy, ensure licensed clinicians control clinical intake and data is handled under privacy/HIPAA as required.
***Avoid promoting illegal or medicalized interventions (e.g., suggesting unsupervised psychedelic use). For psychedelic-adjacent content, keep it educational and refer to legal, licensed programs only.

Create a 1-page flagship offer (Bootcamp) and a $7 tripwire audio pack. Build a conversion landing page + 3 short ad videos or organic reels.

Create 5 free pieces of content (challenge sequence) for social.
- : repurpose cohort snippets, go live weekly in your membership, use members as ambassadors.
Keep offers evidence-based, avoid clinical overreach, and build social proof before big ad spend. The market demand is there; Your job is to package transformation simply and ethically.

Mythological Mushrooms

02/07/2026

Mythological Mushrooms
“Eat Like a God. Trip Like a Legend.”
Do you suffer from boring reality?
Chronically chained to the Matrix?
Does your soul scream for meaning while your 9-to-5 screams, “TPS reports”?
Friend, you don’t need therapy. You need Mythological Mushrooms
Plucked straight from Odin’s beard and watered with Poseidon’s tears
These mushrooms are so potent, Zeus got kicked out of Olympus for snacking on 'em mid-meeting. I seent it.

Side effects may include:
-Speaking fluent Sumerian (even if you never studied it).
-Receiving life advice from a centaur named Craig.
-Crying tears of joy after realizing your houseplant loves you back.
-Accidental enlightenment in aisle 5 of Whole Foods.

Whether you're trying to:
-Unlock your third eye.
-Speak to snakes like Moses on mushrooms
-Reconnect with your alien ancestors.
-Battle inner demons like you're on a Greek epic.
- Or just vibe with a unicorn in a hammock.

These mystical shrooms are your golden ticket to Valhalla, Nirvana, and the nearest forest rave. Alll in one ride. 🤸

WARNING:
Do not operate a chariot, dragon, or Uber while under the influence. Consult your local shaman or Druid before use.

02/01/2026

02/01/2026

https://sitelytic.io/home-1164?am_id=cammgoodho9995

01/29/2026

Mythological Mushrooms is here to bring ancient stories and useful mushroom habits to your kitchen. Then you can join the private group for the exquisitely exotic pleasantries!

Tell us: which mushroom should we cover first? / / / /

Mythological Mushrooms ( ): mushroom recipes, folklore, and science-backed tips that may support focus, calm, and resilience.
Join the group for recipes:
Mythological Mushrooms

1. We blend ancient mushroom folklore with practical, legal uses today.
2. Real recipes, safe sourcing tips, and short science bytes from .
3. Built for curious people who want better mornings, calmer nights, and a little myth in their mug.

We’re a practical blend of folklore and functional mushroom know-how. No illegal advice. We share recipes, reputable sourcing tips, and short science bytes so you can add beneficial mushrooms safely to your life. Join the group for exclusive recipes, live Q&As, and knowledge! Sacred Jester

Privacy: Private: — Keeps discussion higher quality and the algorithm favors private groups for engagement. Community for legal, practical mushroom use. Recipes, sourcing, myths, and low-cost micro-habits. No illegal activity.
We focus on safe, legal uses and do not discuss psychedelics or illegal cultivation. Be kind, be curious, and share what works for you.

Group Rules:
-Be respectful. No harassment, slurs, or personal attacks.
-No spam or repeated promo posts — one pinned weekly “shop” thread allowed.
-Label affiliate posts clearly. Be transparent with links.
-Personal health claims must be framed as personal experiences, not cures. No medical diagnosis.
-Report rule-breakers to admins; don’t handle confrontations publicly. NO REPORTING!

1. Quick answer: Why do you want to join Mythological Mushrooms? (short text)

2. Which mushroom interests you most? (choose one) — Lion’s Mane / Reishi / Chaga / Cordyceps / Foraging & ID / Other / ?

01/13/2026

Mythological Mushrooms is where the mystically miraculous therapeutic superpowers of fungi come alive! Join us on a mission to stop soldier su***de, reprogram mentalities, heal through nutrition, Herbalist Remedies and Holistic Concoctions. Through the fascinating realm of mushroom mythology, and legend. From ancient cultures to modern-day spirituality, we'll explore the symbolic meanings, magical properties, and mystical significance of mushrooms in various traditions. https://sitelytic.io/home-1164?am_id=cammgoodho9995